Abstract -Leucotoxins are regarded as virulence factors of Staphylococcus aureus, but data supporting their importance in infection are scarce. Experimental infections of the mammary glands of six goats with a leucotoxin-producing strain were used to investigate in vivo production of leucotoxin. Leucotoxin M/F' was monitored in milk as well as antibodies to LukM/F' in serum and milk. Leucotoxin antigen was detected by ELISA in milk samples of two goats. The appearance of neutrophils in these samples showed similarity with the altered appearance of neutrophils incubated with purified LukM/F' leucotoxin. Leucotoxic activity was found in the milk samples of these two goats, in particular those of the only goat which developed gangrenous (necrotic) mastitis, and this activity was inhibited by antibodies to LukM/F'. Increases in specific antibody titers occurred in the serum and milk of infected goats, and neutralizing titers increased in serum. The results indicate that the lukM and lukF' genes were functional in vivo, and actively transcribed and translated in the course of mammary infection. These results suggest that LukM/F' can interfere with neutrophil defense activities during infection, and they prompt further studies to investigate the contribution of leucotoxins to staphylococcal mastitis.
INTRODUCTION
Leucotoxins are considered to be virulence factors of Staphylococcus aureus, owing to their toxic activities on several leucocytic cell types. Although direct or indirect contributions to pathogenicity are likely, data supporting the importance of staphylococcal leucotoxins in infection are scarce. Leucotoxins are bicomponent pore-forming toxins that target leucocytes, in particular neutrophilic granulocytes [15] . They constitute a family of * Corresponding author: rainard@tours.inra.fr toxins usually designated by the first component (class S component) that binds to the target cell, followed by the designation of the second component (class F component) that associates to the cellbound first component to finally form an octameric pore: the possible homologous associations for strains of ruminant origins are the gamma hemolysins HlgA/B and HlgC/B, and the leucotoxins LukE/D and LukM/F'. The Panton-Valentine leucotoxin (LukPVL) is rarely found in S. aureus strains associated with ruminant mastitis. The phagocyte-specific activity of leucotoxins would enable S. aureus to interfere with the phagocytic defenses of the host they colonize. A prerequisite for a role of leucotoxins in pathogenesis of infection is synthesis and secretion at infection foci, but evidence of in vivo leucotoxin production are scant: expression of the genes encoding two leucotoxins (luk-PV and hlgCB) was found by RT-PCR in a rabbit model of S. aureus endophtalmitis using a strain of human origin [3] , and a leucotoxin was detected in a few milk samples from cows infected by S. aureus [11] , although its identity was not specified.
Mammary infections are a suitable model for investigating the contribution of leucotoxins to pathogenesis. The most frequently isolated pathogens in mastitis of ruminants are staphylococci, and S. aureus is considered a major pathogen responsible for considerable increases in milk leucocyte concentration and clinical mastitis [2, 4, 18] . Since phagocytosis by neutrophils is an important defense of the mammary gland of ruminants against mastitis-causing bacteria [12, 17] , the production of leucotoxins may confer on S. aureus an increased capacity to resist host defenses and to settle in the mammary gland. Cattle mastitis field isolates are almost all equipped with genes of the leucotoxins LukE/D and hemolysin γ, and a proportion (50 to 80%) possess the genes encoding the LukM/F' leucotoxin [6, 21] . Data concerning mastitis isolates of goat origin are few, but indicate that LukM/F' is also well represented [16] . The most active leucotoxin on bovine neutrophils is LukM/F' [1] . Considering that this leucotoxin is widely found among ruminant mastitis isolates but not among isolates of human or other animal origins [20, 21] , it can be put forward that LukM/LukF' could play a distinctive role in the pathogenesis of ruminant mastitis. Owing to its high activity on neutrophils, this leucotoxin may be the counterpart in ruminants of the Panton-Valentine leucotoxin of human strains of S. aureus. Although the in vitro effects of several staphylococcal leucotoxins have been reported [7, 9] , the in vivo production of leucotoxins by S. aureus during infection is much less documented. In particular, their production during experimentally controlled intramammary infections has never been documented.
The aim of this study was to test whether a LukM/F'-producing strain of S. aureus could induce mastitis and whether leucotoxin could be detected in milk. An indirect means to assess the in vivo production of leucotoxins is to monitor the appearance of antibodies in the course of infection. That is why antibodies to LukM/F' were recorded in serum and milk following infection. The neutralizing activities of normal milk and serum, i.e. before infection, and at different times after infection, were also investigated.
MATERIALS AND METHODS

Intramammary challenge with
S. aureus
One strain of S. aureus (Ch122), isolated from the milk of an infected goat, was used to inoculate mammary glands. This strain was selected from our strain collection on the basis of high production of LukM/F' leucotoxin [16] . It harbors the genes encoding the LukM/F', LukE/D and Hlg leucotoxins, but produces essentially LukM and LukF' when grown in vitro in conventional bacteriological media [16] . It also possesses the genes for hemolysins alpha and beta, is hemolytic on blood agar plates (strong β hemolysis) and produces capsular polysaccharide type 8. The strain was kept at -70
• C in brainheart infusion broth (BHI) supplemented with 7% dimethylsulfoxide (Sigma Chemical Co., St. Louis, MO, USA). A tube of BHI was inoculated overnight with frozen bacteria at 37
• C. Purity of the culture was checked by plating on a blood agar plate.
From the overnight BHI culture, a subculture was made in a tube of BHI for 18 h at 37
• C. The bacteria were pelleted by centrifugation (2000 × g, 20
• C, 15 min) and washed twice with 20 mL of Hanks balanced salt solution (HBSS; Sigma). After the last centrifugation, the pellet was resuspended with 10 mL of HBSS, and adjusted to the required concentration on the basis of the optical density of the suspension (OD 1.0 at 600 nm corresponds to about 2.7 × 10 8 CFU/mL). The inoculum consisted of 0.5 mL of the bacterial suspension adjusted to 20 000 cfu/mL, in a 1 mL disposable syringe fitted with a blunt-ended cannula. Extra-inocula were prepared and 50 µL of their content plated on blood agar to retrospectively check the size of the infectious dose by counting cfu after overnight incubation at 37
• C. The inoculum was found to contain about 16 000 cfu.
Healthy lactating multiparous goat does of Alpine breeds were selected on the basis of the absence of intramammary infections and milk cell concentration less than 200 000 cells/mL. They were housed in a barn on a straw bed in groups of about six animals for several months, and were maintained together with their kids which were allowed free suckling. The care and use of goats conformed to the practices in effect at the INRA Nouzilly Research Center. Challenge exposure was carried out within 2 to 4 months after kidding. Bacteriological examination of milk (half-gland foremilk) was done with a standard procedure [13] one week before inoculation, on the day of inoculation, every other day up to two weeks post-inoculation (pi), then twice a week up to the end of the experiment (4 weeks).
To induce intramammary infections, goats were infused through the teat canal with 0.5 mL of the bacterial suspension within one hour of preparation. Before infusion, teats were swabbed with 70% ethanol, and were gently massaged upwards after infusion. One udder half was inoculated, the other one serving as the control gland. The goats were hand-milked before infusion, and the kids were kept away from the inoculated goats for at least 3 h after inoculation.
Processing of milk samples
Milk samples were taken with asepsis precautions for bacteriological examination and determination of cell content (number and microscopic appearance). Bacterial shedding in milk was semiquantitatively assessed by recording the number of bacterial colonies in 50 µL milk plated on sheep blood esculine agar plates after 24 h of incubation at 37
• C. Within 2 h of sample collection, slides were prepared to microscopically assess the appearance of milk cells. Milk (100 µL + 30 µL fetal bovine serum) was cytocentrifuged (Shandon Southern centrifuge, Shandon Inc. Pittsburgh, PA, USA) and the slides were stained with May-Grünwald-Giemsa before examination under the microscope. Another portion (500 µL) was used for cell count which was performed with a Fossomatic model 90 (Foss Electric, Hillerod, Denmark). The remainder of the milk was centrifuged at 1500 × g for 30 min at 4
• C. The cream was discarded, and the skimmed milk was stored in portions at -20
• C.
Quantitation of leucotoxin components in milk by ELISA
ELISA were performed in 96-well flatbottomed plates (Nunc Immunoplate Maxisorp, Merck Eurolab, Strasbourg, France). Following each incubation step, three washes were carried out with phosphate buffered saline (PBS) supplemented with 0.05% Tween 20, using a MW 96/384 microplate washer (Beckman Coulter Inc., Fullerton, CA, USA). Samples and immune reagents were diluted in PBS containing 0.5% gelatin and phenol red unless otherwise stated. Appropriate dilutions of the immune reagents were dispensed in 100 µL samples and incubated at 37
• C for 1 h unless otherwise stated.
Sandwich ELISA were used to measure the concentrations of LukM and LukF'. The sequence of incubation steps was as follows: (1) coating of the plate with affinity-purified bovine anti-LukM or anti-LukF' (5 µg/mL) in carbonatebicarbonate buffer 0.1 M pH 9.6 overnight at 4
• C; (2) blocking with 0.5% gelatin for 30 min; (3) incubation with milk samples undiluted or diluted 1 / 4 , along with serial dilutions of purified LukM or LukF' to establish the standard curve; (4) incubation with rabbit anti-LukM or anti-LukF' immune serum diluted 1/1000; (5) incubation with peroxidase-conjugated goat antibody to rabbit IgG (Jackson Immunoresearch Laboratories, West Grove, PA, USA) diluted 1/10000; (6) incubation with a 2% dilution of 2,2'-azino-bis(3-ethylbenzthiazoline-sulfonate) (ABTS; Sigma) in 0.1 M citrate buffer pH 4.2, with the addition of 0.075% hydrogen peroxide just before use. The optical density was read at 414 nm on a microplate reader (BioKinetics reader; BioTek Instruments, Winooski, VT, USA). Values expressed in ng/mL were extrapolated using linear regression from the standard curve obtained with the known concentrations of LukM or LukF'.
Titration of leucotoxic activity in milk and neutralization by specific antibodies
The assay is based on the shape change (spreading) induced on PMN by staphylococcal leucotoxins, as described by [1, 16] . PMN were isolated from goat blood as described [1] , and adjusted to 2 × 10 6 /mL in RPMI 1640 without bicarbonate, with 20 mM Hepes (Sigma) and 1 mg/mL bovine serum albumin (low endotoxin, Uptima Interchim, Montluçon, France). Viability of PMN was higher than 98% (exclusion of trypan blue) and more than 95% of cells were granulocytes. Flat-bottomed 96-well microtiter plates were coated with 1 mg/mL BSA in HBSS for 15 min at 37
• C. After washing, 80 µL of serial twofold dilutions of the sample under test were distributed in the wells of the plate, 20 µL of PMN suspension was added, and the plate was incubated at 37
• C for 60 min. Then, the shape of PMN was examined with an inverted microscope. The inverse of the last dilution inducing the spreading of more than 90% of the cells was taken as the leucotoxic titer. Positive control was carried out with purified LukM/F' (2 nM) and negative control with RPMI 1640.
Neutralization of the leucotoxic activity of milk samples was achieved by adding affinity-purified rabbit Ab against LukM and LukF' [16] , and incubating for 4 h at 4
• C before performing the PMN spreading assay. Control of specificity was carried out by incubating the milk samples with the same concentration (see Results) of affinity-purified rabbit Ab to hen ovalbumin.
Quantitation of Ab to LukM and LukF' by ELISA
Antibodies to LukM and to LukF' were titrated in milk and sera with indirect ELISA. Washings, diluting buffer and incubations were as for the leucotoxin components ELISA. The sequence of incubation steps was as follows: (1) coating of the plate with 2 µg/mL of either purified LukM or LukF' [16] in carbonate-bicarbonate buffer 0.1 M pH 9.6; (2) blocking with 0.5% gelatin for 30 min; (3) incubation with sera diluted 1/500 or milk diluted 1 / 4 , along with serial dilutions of immune goat serum to establish the standard curve; (4) incubation with rabbit anti-LukM or anti-LukF' immune serum diluted 1/1000; (5) incubation with 1/10000 dilution of peroxidase-conjugated rabbit antibody to goat IgG (Jackson Immunoresearch Laboratories); (6) ABTS substrate. The optical density was read at 414 nm on a microplate reader (BioKinetics reader). Caprine sera and milk were titrated in units by extrapolation, using linear regression, from the standard curve obtained with the dilutions of the immune serum which was arbitrarily assigned 10 000 Ab units. To obtain this serum, a goat was immunized three times at two-month intervals with 50 µg of LukM and LukF' (in separate preparations) emulsified in incomplete Freund's adjuvant. The two toxin components were injected subcutaneously at separate sites. Serum was obtained two weeks after the last injection.
Assay of neutralizing activity of serum or milk
The capacity of serum or milk to neutralize the cytotoxic activity of LukM/LukF' was measured with the PMN spreading assay. The mixture (ratio 1/1) of 50 µL LukM and LukF' at 4 nM concentration was incubated for 1 h at 37
• C with serial twofold dilutions (50 µL) of serum in wells of 96-well microtiter plates. Then, 20 µL of caprine PMN suspension (2 ×10 6 /mL) were added, and the plate was incubated for 1 h at 37
• C at rest. Visual assessment of the spreading of PMN was done under an inverted microscope. The inverse of the last dilution of serum precluding the toxin-induced spreading of PMN was taken as the neutralizing titer. A positive control was performed with immune goat serum. The immune serum neutralized 2 nM LukM/F' up to the 1/400 dilution. Owing to its opacity, normal milk had to be diluted at least four times to allow visual assessment of PMN spreading, but serum-like mammary secretion could be tested undiluted.
Statistical analysis
The results were analyzed with the StatXact 5 software (Cambridge, MA, USA), using the permutation test for paired samples and Spearman correlation (exact nonparametric inference).
RESULTS
Clinical signs
Mild mastitis symptoms were evoked by intramammary inoculation of about 16 000 cfu of S. aureus ch122 in 5 of the 6 goats. There were local signs of moderate intensity (sensitive to palpation) during the day following the challenge, then no local or systemic clinical signs. One goat (1214) developed a severe form of mastitis, with local and systemic signs as early as 12 h pi. At 24 h pi, the inoculated gland was swelled, red, tender, and there were numerous clots in the milk. At 48 h pi, a blue skin circular area (about 7 cm in diameter) was visible at the rear of the gland, signalling a case of gangrenous (necrotic) mastitis. The decision was made to slaughter the animal for ethical reasons. The mammary secretion at this time was serum-like.
Inflammatory response and shedding of bacteria
It was not possible to determine precisely the cell concentration in the milk of the goat (1214) which developed gangrenous mastitis, because of massive clotting, nevertheless cell concentrations of the liquid phase markedly increased as early as day 1 pi (Fig. 1) . Cell concentrations increased sharply in the five inoculated glands which developed mild mastitis on the day after inoculation. Thereafter, the course of infection differed widely among animals (Fig. 1) . Cell concentrations remained elevated in the milk of two goats but declined in the milk of the other three. One goat got rid of the infection very early (goat 1398): bacteria were not isolated from milk after day 2 pi. Goat 1389 never shed cultivable S. aureus, despite a strong initial cellular response in milk, suggesting that bacteria multiplied initially in the gland but were promptly eliminated. Pure cultures of S. aureus were consistently recovered from milk of the other three goats until the end of the experiment. The highest shedding of S. aureus occurred in the milk of goat 1214, with bacterial concentration >100 000 cfu/mL. The second highest shedding was by goat 1208. At day 1 pi, the shedding was more than 10 000 cfu/mL, about 5000 cfu/mL at day 2 pi, and only 1500 cfu/mL at day 3 pi. In milk samples of the other goats, the concentration of bacteria remained below 1000 cfu/mL.
Leucotoxin in milk of S. aureusinfected glands
The milk was searched for leucotoxin by means of sandwich ELISA. With the LukM-ELISA, capable of detecting 0.4 ng of toxin per mL, all the milk samples were negative, except four samples from infected glands of goats 1208 and 1214. Concentrations of 4.8 and 6.2 ng/mL were found in the milk of goat 1208, and 140 and 180 ng/mL in the milk of goat 1214, at days 1 and 2 pi, respectively. The component LukF' was also detected in these samples, at concentrations comparable to that of LukM (203 ng/mL in milk of goat 1214 at day 2 pi).
At day 2 pi, the milk of goat 1214, which suffered from gangrenous mastitis, was examined microscopically. A cytospin preparation and May-Grünwald-Giemsa staining showed cells with swelled rounded nucleus, and no intact neutrophils (Fig. 2) . This cell appearance contrasted with the intact morphology of neutrophils in the milk of the infected glands of the other goats, but was quite comparable to that of blood neutrophils treated in vitro with LukM/LukF' leucotoxin (Fig. 2) .
The cytotoxic activity was titrated in milk of goat 1214 at day 2 pi by the PMN spreading assay. Activity was seen up to dilution 1/20, which corresponds to 180/20 = 9 ng/mL of leucotoxin. Affinitypurified antibodies to LukM and LukF' were used to check that the spreading activity was due to a member of the leucotoxin family. A molar ratio of 10 to 1 was chosen to attempt blocking the toxin activity: antibodies to LukM were added to the milk sample at a final concentration of 10 µg/mL, along with 10 µg/mL of antibodies to LukF', and the mixture was incubated for 4 h at 4
• C before addition of caprine neutrophils. Antibodies totally inhibited the spreading of neutrophils, even in undiluted milk. Anti-ovalbumin antibodies (20 µg/mL, final concentration) did not inhibit the activity of milk, which remained able to induce neutrophil spreading at the 1/20 dilution. Cytocentrifugation and May-Grünwald-Giemsa staining was performed to check the morphology of the neutrophil nucleus. The results corresponded to the characteristic alteration provoked by leucotoxins, and the cytotoxic effect was inhibited by antibodies to LukM/F' but not by antibodies to ovalbumin (not shown) in milk samples of goat 1214. Altered cells were also seen in the milk sample of goat 1208 at day 1 pi (not shown), but not at day 2 pi (Fig. 2). 
Antibody response to infection: leucotoxin ELISA titers
Before infection, Ab to the two components of the toxin were detected in the serum of the six goats, with wide variations among animals (Fig. 3) . Ab titers in serum of goat 1214 before inoculation were comparable to the titers of other goats, 356 and 48 for Ab anti-LukM and anti-LukF', respectively. Only three goats developed Ab titers higher than pre-infection titers. Titers began to increase at days 7 pi, and a peak was reached at day 21 pi. Titers remained low in the serum of the two goats that eliminated precociously their infection (No. 1389 and 1398). The highest titers were in the serum of goat 1208, which had the highest numbers of bacteria in milk. Differences between anti-LukM or anti-LukF' ELISA titers at day 0 versus either day 14, 21 or 28 pi were statistically significant (p = 0.03; permutation test for two related samples).
In milk, initial Ab titers were very low, from 1/2000 to 1/9250 of serum titers. In the milk of inoculated glands, there was a slight initial increase in Ab titers on day 1 pi, probably as a result of the exudation of plasma associated with the inflammatory response. Nevertheless, marked increases in titers were not seen before day 14 pi and later on (Fig. 4) , probably at least partly as a result of combined exudation of plasma and of increases in blood Ab titers. As in serum, the Ab titers did not augment in the milk of the goats 1289 and 1398 (Fig. 4) . Differences between ELISA titers (anti-LukM + antiLukF') in the milk of inoculated glands at day 0 versus either day 14, 21, or 28 pi were statistically significant (p = 0.03; permutation test for two related samples). In control healthy glands, Ab titers followed an upward trend from day 14 pi, although not significant (Fig. 5) . The ratio of Ab titers after/before infection ranged from 2 to 5 in healthy glands and 10 to 30 in infected glands.
Neutralizing antibodies in serum and milk
The serum of all the goats exerted some neutralizing activity on LukM/F', but it was rather low because undiluted or at least 10% serum were necessary to block the activity of two times the lowest toxin concentration capable of inactivating neutrophils, i.e. 1-2 nM (18-36 ng/mL) (Fig. 5) . In contrast, the serum of the immunized goat inhibited the toxic activity of the toxin up to the 1/400 dilution. At the peak of the ELISA serum Ab titers, the neutralizing titers were increased (Fig. 6 ): the median value, which before inoculation was 10, reached 40. The correlation between the neutralizing and the ELISA titers were of 0.86 and 0.95 at days 0 and 21 pi (p = 0.083), respectively, suggesting that most of the induced Ab were neutralizing. Neutralizing activity was not detected in milk, except in the samples taken 14, 21 and 28 days pi from the inoculated mammary gland of goat 1208, which had the highest milk Ab titers. Nevertheless, only the smallest dilution that can be tested due to the opacity of milk (1/4) was inhibitory.
DISCUSSION
The main objective of this study was to investigate whether leucotoxins are produced in vivo in the course of mammary infection. Several lines of evidence indicate that this was the case. First, leucotoxin was detected in certain milk samples by ELISA. Second, leucotoxin-specific cytotoxic activity was present in milk samples of a case of gangrenous mastitis. Third, Ab titers increased in the serum and milk of all the animals that developed lasting infection.
The direct demonstration of intramammary production of leucotoxins by their detection in milk is hindered by the dilution by milk of the minute amounts which are likely to be generated in the foci of infection, unless high bacterial concentration are reached in milk where leucotoxin production could then take place. The occurrence of naturally acquired antibodies and potential elicited antibodies could also interfere with immunochemical detection of the toxins. In the present study, both antigenic and cytotoxic leucotoxin activities were found in several samples of milk during infection. Twenty times the minimal concentration active on caprine PMN was found in mammary secretion during the case of gangrenous mastitis, along with massive shedding (more than 10 5 cfu/mL) of staphylococci.
Others have reported the detection of leucotoxin in milk samples from cows with chronic staphylococcal mastitis, but not leucotoxic activity by milk from infected glands [11] . In the present study, cytotoxic activity was found in milk of gangrenous mastitis. The inhibition of this cytotoxic activity by specific but not by unrelated Ab demonstrated that it was due to a toxin belonging to the family of binary staphylococcal leucotoxins and not to another staphylococcal cytotoxin such as a hemolysin or delta-toxin. The cytotoxic activity found in milk of gangrenous mastitis was high, since this milk withstood a twenty-fold dilution before loosing its effect on caprine neutrophils. This finding agreed with the appearance in the milk samples of cells which showed the alterations characteristic of leucotoxin activity (Fig. 2) . The identity of the leucotoxin detected in milk cannot be ascertained only on the basis of ELISA, because of the cross-reactivity of Ab due to sequence identity between class S components (55 to 72%) and class F components (71 to 79%), respectively [14] . Nevertheless, it is probable that the major leucotoxin in positive samples was LukM/LukF', for two reasons. First, S. aureus Ch122 essentially produces this leucotoxin [16] . Second, the robust cytotoxic activity of milk of gangrenous mastitis strongly suggests that the leucotoxin produced was indeed LukM/F', because at the least active concentration (9 ng/mL in the 1/20 dilution), none of the other leucotoxins are active on caprine neutrophils, since they are at best 10 times less active than LukM/F' [1] . In fact, the toxin in milk seemed to be even slightly more efficient than purified LukM/F', which is active down to about 18 ng/mL on caprine neutrophils ( [16] and this study). Possibly other toxins, such as hemolysins, secreted in milk along with leucotoxins, contributed to this strong activity.
Indirect evidence that leucotoxins were generated in vivo was the increases in antibody titers during or following infection, assuming that rising titers result from the production of the corresponding antigen by the mastitis-causing bacteria. The sharp rises in Ab titers which occurred in the 14 days following infection (Fig. 3) indicate that leucotoxins were produced in vivo. Persistence of infection was necessary to elicit Ab, since the two goats that eliminated staphylococci from the inoculated gland within 2 days after inoculation did not develop Ab. On the contrary, mild mastitis cases, associated with moderate shedding of bacteria, were sufficient to induce Ab, although bacterial multiplication was insufficient for Ag to be detected in most milk samples. Higher leucotoxin Ab ELISA values in milk and serum of cows with naturally acquired S. aureus mastitis than in mastitis-free cows has been reported [10] . This suggests that chronic infections, mainly subclinical, elicit Ab responses to leucotoxins also in cattle. A parallel can be made with another potential virulence factor of mastitis-causing S. aureus, enterotoxin D. This enterotoxin was recently shown to be produced in vivo and was found in the milk of a few infected cows, at concentrations active on bovine lymphocytes [19] . Specific Ab were elicited, which were able to neutralize the toxin. From these results and those of the present study, it can be put forward that during chronic mammary infections, although subclinical during most of their duration, toxins are produced which are capable of eliciting systemic Ab responses.
Outcomes of infections ranged from prompt elimination without clinical signs to gangrenous mastitis. The group of inoculated goats was not very homogeneous, and the conditions of their rearing did not preclude contact with S. aureus prior to inoculation. This may account for the heterogeneity of the responses to infection. No clear association between Ab titers before inoculation and severity of mastitis was obvious in this study.
The possession of lukPV genes by isolates of human origin appears to be associated with increased severity, ranging from severe cutaneous infection to necrotizing pneumonia [5, 8] . It may be that LukM/F', which is the most active leucotoxin on ruminant PMN, as the Panton-Valentine leucocidin is on human PMN, contributes to the severity of mastitis. The leucotoxin LukM/F' seems to be an attribute of strains isolated from mastitis of ruminants, since it is not present in the genome of strains isolated from other hosts [20, 21] . Recently, it has been shown that staphylococcal exosecretion containing LukM/F' can provoke an inflammatory reaction when infused in the mammary gland [22] , suggesting that this leucotoxin can play a part in the severity of the inflammatory response. The in vivo production of LukM/F' is a prerequisite for a contribution to pathogenesis, and the present study brings arguments that support this production during mammary infection. Moreover, the observed case of gangrenous (necrotic) mastitis suggests that LukM/F' could play a role in this syndrome. It can be hypothesized that when the population of a high-leucotoxinproducing strain reaches a sufficient size in the mammary gland, leucotoxin is produced in amounts that overwhelm the natural neutralizing Ab. Then phagocytic defenses are altered, and bacteria multiplication escapes control. Accordingly, the conditions would be met for gangrenous mastitis to develop. This hypothesis would be worth testing with a mutant strain defective in LukM production.
In conclusion, this study shows that the lukM gene was functional, and actively transcribed and translated in the course of mammary infection. Leucotoxin and cytotoxic activity were found in a few milk samples, and this activity was inhibited by Ab to LukM/F'. Antibody titers increased when mammary infection lasted more than a few days. In a case of gangrenous mastitis, milk cells displayed the characteristic appearance of neutrophils incubated with purified LukM/F'. It can be concluded that leucotoxin, most likely LukM/F', was produced during mammary infection, and the high leucotoxic activity found in gangrenous mastitis secretion suggests that this toxin could play a role in the pathogenesis of severe forms of mastitis.
